Value, affordability and decision making

Data Governance Arrangements for Real-World Evidence: South Korea

Why Do Immigrants Report Lower Life Satisfaction?

News
January 2017

New Publication: Assessing Evidence and Access Associated with NICE HTA Decisions Categorised as “Recommended in Line with Clinical Practice”

‘Macro’ Evaluation of the NIHR Oxford Biomedical Research Centre

Age and Utilities: Issues for HTA

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Transferability of HTA

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Delivering an Outcomes-based NHS: Creating the Right Conditions

Policy Options for Formulary Development in Middle-income Countries

00
13
14
15
16
17
18
19
20
21
00

Latest Research & Publications

Additional Elements of Value for Health Technology Assessment Decisions

‘Macro’ Evaluation of the NIHR Oxford Biomedical Research Centre

Incentives for New Drugs to Tackle Anti-Microbial Resistance

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

Transferability of HTA

How can HTA meet the needs of health system and government decision makers?

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Age and Utilities: Issues for HTA

All Publications

Filter results by

Filter results by

Data Governance Arrangements for Real-World Evidence: South Korea

Why Do Immigrants Report Lower Life Satisfaction?

New Publication: Assessing Evidence and Access Associated with NICE HTA Decisions Categorised as “Recommended in Line with Clinical Practice”

‘Macro’ Evaluation of the NIHR Oxford Biomedical Research Centre

Age and Utilities: Issues for HTA

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Transferability of HTA

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Delivering an Outcomes-based NHS: Creating the Right Conditions

Policy Options for Formulary Development in Middle-income Countries

Share on Mastodon